N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-tetrahydrofuran-2-yl]purin-6-yl]benzamide(CAS: 81265-93-2)

N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-tetrahydrofuran-2-yl]purin-6-yl]benzamide (CAS: 81265-93-2) is subject to GHS classification, REACH regulations, and FDA/EPA requirements. It should be handled according to these guidelines to ensure safe and compliant use in industrial and research settings.

While N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-tetrahydrofuran-2-yl]purin-6-yl]benzamide (CAS: 81265-93-2) is a specific compound, alternatives such as related purines or benzamides may be used in synthesis. Common alternative reagents and substitutes include purine derivatives and other benzamide analogs.

The market for N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-tetrahydrofuran-2-yl]purin-6-yl]benzamide (CAS: 81265-93-2) is primarily driven by its use in research and specialized pharmaceutical applications. Emerging trends include its application in drug discovery and personalized medicine. Price trends and demand are closely linked to advancements in these fields.

Waste containing N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-3-[tert-butyl(dimethyl)silyl]oxy-4-hydroxy-tetrahydrofuran-2-yl]purin-6-yl]benzamide (CAS: 81265-93-2) should be collected and disposed of according to hazardous waste regulations. Proper incineration or professional waste disposal services should be used. Ensure all environmental protection precautions are followed to minimize environmental impact.